Every Form 4 that Danaher Corporation (DHR) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow DHR and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full DHR filings page.
Danaher (DHR): Director A. Shane Sanders reported the acquisition of 186.308 phantom shares on 10/31/2025 on a Form 4. The award was made under the Non-Employee Directors Deferred Compensation Plan, which converts deferred director fees (and dividend accruals) into notional shares based on the NYSE closing price on the quarterly date. The filing notes a reference closing price of $215.38.
Following this transaction, Sanders beneficially owned 2,536.686 derivative securities (phantom shares), held directly. Phantom shares convert into Danaher common stock on a one-for-one basis upon distribution, and the reporting person is fully vested in all amounts deferred under the plan.
Danaher (DHR) reported a routine insider transaction: director Linda Filler acquired 13.208 phantom shares on 10/31/2025 under the company’s Non‑Employee Directors Deferred Compensation Plan. These notional units track Danaher common stock and are valued using the NYSE closing price of $215.38 on the transaction date.
The phantom shares convert into Danaher common stock on a one‑for‑one basis upon distribution, and the reporting person is fully vested under the plan. Following the transaction, Filler beneficially owned 8,903.266 derivative securities, reported as directly owned.
Danaher Corporation (DHR) reported an insider equity compensation update. Director Teri List acquired 11.322 phantom shares on 10/31/2025 under the Non-Employee Directors Deferred Compensation Plan, which converts deferred cash fees into notional Danaher common stock equivalents based on the closing price on the transaction date.
The filing lists a reference price of $215.38 per share, reflecting the NYSE closing price used for the quarter’s deferral calculation. Phantom shares convert into Danaher common stock on a one-for-one basis upon distribution, and the reporting person is fully vested in amounts deferred under the plan. Following this transaction, Ms. List beneficially owned 7,631.994 derivative (phantom) shares, held directly.